1. 9. Efficacy and safety of a ready-to-use liquid formulation of abobotulinumtoxinA lyophilisate in moderate to severe glabellar lines: results of a phase 2 randomized, placebo-controlled clinical trial. (January 2015) Authors: Ascher, Benjamin; Kestemont, Philippe; Boineau, Dominique; Bodokh, Isaac; Stein, Annette; Dendorfer, Markus; Heckmann, Marc; Pavicic, Tatjana; Tse, Anissa; Picaut, Philippe; Rzany, Berthold Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients. (5th April 2019) Authors: Rzany, Berthold-Josef; Ascher, Benjamin; Avelar, Rui L; Bergdahl, Jesper; Bertucci, Vince; Bodokh, Isaac; Carruthers, James Alastair; Cartier, Hugues; Delmar, Henry; Denfeld, Ralf; Gross, John E; Heckmann, Marc; Hedén, Per; Hilton, Said; Inglefield, Christopher; Ogilvie, Patricia; Sattler, Gerhar... Journal: Aesthetic surgery journal Issue: Volume 40:Number 4(2020) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Aktualisierung der S1‐Leitlinie zur Definition und Therapie der primären Hyperhidrose. (10th July 2018) Authors: Rzany, Berthold; Bechara, Falk G.; Feise, Konstantin; Heckmann, Marc; Rapprich, Stefan; Wörle, Birgit Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 16:Number 7(2018) Page Start: 945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines. (19th March 2021) Authors: Ascher, Benjamin; Rzany, Berthold; Kestemont, Philippe; Hilton, Said; Heckmann, Marc; Bodokh, Isaac; Noah, Ernst Magnus; Boineau, Dominique; Kerscher, Martina; Volteau, Magali; Le Berre, Philippe; Picaut, Philippe Journal: Aesthetic surgery journal Issue: Volume 41:Number 11(2021) Page Start: 1338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of Self‐Esteem and Depression Symptoms in Depressed and Nondepressed Subjects Treated with OnabotulinumtoxinA for Glabellar Lines. Issue 7 (6th March 2013) Authors: Hexsel, Doris; Brum, Cristiano; Siega, Carolina; Schilling‐Souza, Juliana; Forno, Taciana Dal'; Heckmann, Marc; Rodrigues, Ticiana C. Journal: Dermatologic surgery Issue: Volume 39:Issue 7(2013) Page Start: 1088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial. (14th February 2017) Authors: Ascher, Benjamin; Kestemont, Philippe; Boineau, Dominique; Bodokh, Isaac; Stein, Annette; Heckmann, Marc; Dendorfer, Markus; Pavicic, Tatjana; Volteau, Magali; Tse, Anissa; Picaut, Philippe; Rzany, Berthold Journal: Aesthetic surgery journal Issue: Volume 38(2018)Supplement 2 Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines. (20th March 2019) Authors: Ascher, Benjamin; Rzany, Berthold; Kestemont, Philippe; Hilton, Said; Heckmann, Marc; Bodokh, Isaac; Noah, Ernst Magnus; Boineau, Dominique; Kerscher, Martina; Volteau, Magali; Le Berre, Philippe; Picaut, Philippe Journal: Aesthetic surgery journal Issue: Volume 40:Number 1(2020) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data. (4th August 2022) Authors: Solish, Nowell; Ascher, Benjamin; Avelar, Rui L; Bertucci, Vince; Bodokh, Isaac; Carruthers, Jean; Cartier, Hugues; Delmar, Henry; Denfeld, Ralf; Heckmann, Marc; Hedén, Per; Hilton, Said; Inglefield, Christopher; Ogilvie, Patricia; Rzany, Berthold-Josef; Sattler, Gerhard; Sebastian, Michael; Swif... Journal: Aesthetic surgery journal Issue: Volume 42:Number 12(2022) Page Start: 1460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Response to "Facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA PRO Guidance". (22nd September 2020) Authors: Ascher, Benjamin; Rzany, Berthold; Kestemont, Philippe; Hilton, Said; Heckmann, Marc; Bodokh, Isaac; Noah, Ernst Magnus; Boineau, Dominique; Kerscher, Martina; Volteau, Magali; Le Berre, Philippe; Picaut, Philippe Journal: Aesthetic surgery journal Issue: Volume 40:Number 12(2020) Page Start: NP710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial. (24th September 2019) Authors: Ascher, Benjamin; Rzany, Berthold; Kestemont, Philippe; Hilton, Said; Heckmann, Marc; Bodokh, Isaac; Noah, Ernst Magnus; Boineau, Dominique; Kerscher, Martina; Volteau, Magali; Le Berre, Philippe; Picaut, Philippe Journal: Aesthetic surgery journal Issue: Volume 40:Number 9(2020) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗